PC
Procyon Corporation
PCYN · OTC
$0.27 +0.00% (+$0.00)
1M -7.69%
Market Cap $1.95M
P/E Ratio -
Div. Yield -
ROE 14.39%
Bulios Fair Price
$0.2
25.9% downside
Current Price
$0.27
Undervalued Fair Value Overvalued
According to Bulios Fair Price, PCYN is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
2/9Valuation
59 /100
Fair P/S 0.39x
P/B 0.85x
EV/EBITDA 19.53x
Growth
57 /100
Stable Book val. growth 4.43%
Rev. growth 11.29%
FCF growth N/A
Profitability
18 /100
Weak Net margin 6.84%
Op. margin 4.65%
FCF margin 2.51%
Quality
15 /100
Poor ROE 14.39%
ROA 10.65%
Asset turnover 1.56x
Debt
100 /100
Low Current ratio 3.08x
Net debt/EBITDA -0.06x
Debt/Equity 0.14x
Stability
33 /100
Unstable Rev. volatility 19.27%
EPS volatility 261.50%
Profitable years 1
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about PCYN
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Justice W. Anderson
Employees
19
Headquarters
Oldsmar